ALFA Finder
14:30 IST
NSE
Acquisition
Vilin Bio Med Acquisition
Vilin Bio Med held NCLT-convened meetings to approve a scheme of amalgamation with Chemgenix Laboratories. Voting results remain pending in the Scrutinizer's report.
Vilin Bio Med Ltd
- Share price
- ₹52.00
- Market cap
- ₹79.30 Cr
- Revenue (annual)
- ₹42.26 Cr
- Net profit (annual)
- ₹1.93 Cr
- P/E (TTM)
- 41.1×Sector 43.8×
- Promoter holding
- 56.65%+0.00% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Merger & Restructuring 3Management Change 3Financial Results 2Board Meeting Date 2Annual General Meeting 2Acquisition 2Promoter Reclassification 1Capital Structure Change 1Business Update 1
Time
2 announcements with these filters
15:14 IST
NSE
Acquisition
Vilin Bio Med Acquisition
Vilin Bio Med disclosed NCLT Hyderabad allowed its amalgamation with Chemgenix Laboratories Pvt Ltd. The order directs convening shareholder and creditor meetings for both companies.